-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Goldenwell Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2021 to Q3 2024.
- Goldenwell Biotech, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$23.1K, a 34.9% increase year-over-year.
- Goldenwell Biotech, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$125K, a 87.7% increase year-over-year.
- Goldenwell Biotech, Inc. annual Operating Income (Loss) for 2023 was -$117K, a 88.1% increase from 2022.
- Goldenwell Biotech, Inc. annual Operating Income (Loss) for 2022 was -$985K, a 733% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)